| (S)-armepavine from Chinese medicine improves experimental autoimmune crescentic glomerulonephritis. | |
| | |
MedLine Citation:
|
PMID: 20551296 Owner: NLM Status: In-Process |
Abstract/OtherAbstract:
|
OBJECTIVE: Intra-renal T cells and macrophages play a key pathogenic role in the development and progression of glomerular crescents. We aimed to establish (S)-armepavine [(S)-ARM], a major bioactive compound of a Chinese medicinal plant, Nelumbo nucifera, as a potential therapeutic agent in the treatment of autoimmune crescentic glomerulonephritis (ACGN). METHODS: A mouse ACGN model associated with T-cell dysregulation, was used to evaluate the therapeutic effects of (S)-ARM on the rapidly progressive glomerular disorder. RESULTS: The results showed that (S)-ARM administered in the established phase of ACGN is capable of dramatically decreasing glomerular crescents in the kidney and improving proteinuria and renal dysfunction. These effects were associated with greatly inhibited infiltration of T cells/macrophages and suppressed nuclear factor (NF)-κB activation in the kidney, lowered serum levels of autoantibodies and both serum and intra-renal levels of pro-inflammatory cytokines, suppressed T/B-cell activation and T-cell proliferation of the spleen, reduced glomerular immune deposits and apoptosis in both the spleen and kidney in (S)-ARM-treated ACGN mice, compared with the vehicle-treated (disease control) group of ACGN mice. CONCLUSION: We demonstrated therapeutic effects of (S)-ARM on ACGN as a result of: (i) early systemic negative modulation of T/B cells; (ii) intra-renal regulation of combined NF-κB activation and mononuclear leucocytic infiltration, thereby preventing glomerular crescent formation; and (iii) protection from apoptosis in both the spleen and kidney. |
| | |
Authors:
|
Shuk-Man Ka; Yuh-Chi Kuo; Pay-June Ho; Pei-Yi Tsai; Yu-Juei Hsu; Wei-Jern Tsai; Yun-Lian Lin; Chien-Chang Shen; Ann Chen |
Related Documents
:
|
16281956 - Hyporesponsiveness to erythropoietic therapy due to chronic inflammation. 7837786 - Nitric oxide mediates immunologic injury to kidney mesangium in experimental glomerulon... 10906156 - Strong and selective glomerular localization of cd134 ligand and tnf receptor-1 in prol... 19959716 - A spleen tyrosine kinase inhibitor reduces the severity of established glomerulonephritis. 21511696 - Heme oxygenase-1 induction contributes to renoprotection by g-csf during rhabdomyolysis... 11454906 - Metallothionein inhibits doxorubicin-induced mitochondrial cytochrome c release and cas... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2010-06-15 |
Journal Detail:
|
Title: Rheumatology (Oxford, England) Volume: 49 ISSN: 1462-0332 ISO Abbreviation: Rheumatology (Oxford) Publication Date: 2010 Oct |
Date Detail:
|
Created Date: 2010-09-13 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100883501 Medline TA: Rheumatology (Oxford) Country: England |
Other Details:
|
Languages: eng Pagination: 1840-51 Citation Subset: AIM; IM |
Affiliation:
|
Department of Pathology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Cellular and Molecular Mechanisms of Photodynamic Hypericin Therapy for Nasopharyngeal Carcinoma cel...
Next Document: A population study of the frequency of high-dose acetaminophen prescribing and dispensing.